Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Physician-led Trials to Start on New Indication for Irinotecan
October 14, 2002
- Korosho Pledges to Smoothly Implement New Blood Law
October 14, 2002
- Korosho to Give Priority to Useful Drugs in Clinical Trial Consultation
October 14, 2002
- New ADR Information System under Investigation
October 14, 2002
- BUSINESS NEWS IN BRIEF
October 14, 2002
- WORLD NEWS IN BRIEF
October 14, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
October 14, 2002
- New Chugai Aims to Obtain 5% Market Share in 2005: President Nagayama
October 14, 2002
- Denka Seiken to Develop Tissue Culture Influenza Vaccines
October 14, 2002
- Suzuken Ends Acquisition of Ohmori to Regain the Top Position
October 14, 2002
- MPRF Invites Applications for Research Grants in Psychiatry
October 14, 2002
- AstraZeneca Agrees with NicOx on CINODs Development
October 14, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
October 14, 2002
- Korosho to Reorganize PFSB
October 7, 2002
- DIAGNOSTIC NEWS IN BRIEF
October 7, 2002
- Mr Miyauchi Criticizes Korosho for Its Opposition to Deregulation
October 7, 2002
- Nippon Keidanren Calls For Simplification of Application for Medical Devices
October 7, 2002
- PFSB to Accelerate Introduction of Fast-Track System
October 7, 2002
- Olympus Sets Up Marketing Subsidiary in Sao Paulo
October 7, 2002
- Drugs for 21st Quality Reevaluation Announced
October 7, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…